THNR ETF

$23.94
Screen 3,400+ ETFsFind similar ETFs with lower fees
Showing top 20 of 23 holdings— Unlock all holdings(as of Mar 31, 2026)
#Ticker ↕Name ↕Weight ↓Shares ↕Mkt Value ↕Share ChgSectorIndustry
1NVO:OSNovo-Nordisk A/S-Spons Adr11.89%13,431$493.6K••••••••••••••••••••••
2LLYEli Lilly & Co11.56%522$480.1K••••••••••••••••••••••
3REGNRegeneron Pharmaceuticals, Inc.6.77%364$281.2K••••••••••••••••••••••
4AMGNAmgen Inc.6.27%740$260.4K••••••••••••••••••••••
54519:TKChugai Pharmaceutical Co., Ltd6.00%4,600$249.0K••••••••••••••••••••••
61093:HKCSPC Pharmaceutical Group Limited Shs5.03%180,000$208.9K••••••••••••••••••••••
7ABBVAbbvie Inc4.75%907$197.3K••••••••••••••••••••••
8ARWRArrowhead Pharmaceuticals Inc4.68%3,100$194.4K••••••••••••••••••••••
9AZN:LNDeveloped Markets Astrazeneca Plc Sponsored Adr4.66%980$193.3K••••••••••••••••••••••
10PFEPfizer, Inc.4.62%6,828$191.7K••••••••••••••••••••••
11MRKMerck & Company Inc4.48%1,546$186.0K••••••••••••••••••••••
12ROG:SMRoche Holding Ag4.46%473$185.2K••••••••••••••••••••••
134507:JPShionogi & Co Ltd4.46%8,500$185.3K••••••••••••••••••••••
141801:HKInnovent Biologics Inc4.43%17,000$184.1K••••••••••••••••••••••
15AGPXXInvesco Government & Agency Portfolio, Institutional Class2.97%123,112$123.1K••••••••••••••••••••••
16SRRKScholar Rock Holding Corp2.37%2,005$98.6K••••••••••••••••••••••
17VKTXViking Therapeutics Inc Com2.21%2,818$91.7K••••••••••••••••••••••
18-Aud/USD Fwd 202603182.05%85,097$85.1K••••••••••••••••••••••
19GPCR:SHStructure Therapeutics Inc Adr2.02%1,738$83.8K••••••••••••••••••••••
20ZEAL:COZealand Pharma As1.74%1,584$72.1K••••••••••••••••••••••
3+ more holdings available
See all 23 holdings with sector, industry, share changes & CSV export
Unlock All Holdings — $149 $60/mo
Limited to first 500 subscribers - Cancel anytime

THNR ETF All Holdings

THNR holdings total 23 positions. The top 10 holdings account for 66.2% of the fund, led by Novo-Nordisk A/S-Spons Adr at 11.9%, Eli Lilly & Co at 11.6%, Regeneron Pharmaceuticals, Inc. at 6.8%.

THNR portfolio concentration is relatively high, with the top 10 representing 66.2% of total assets. The largest sector exposure is Health Care at 75.7%.

THNR sector allocation provides a detailed breakdown. THNR overlap tool shows how holdings compare to other funds in your portfolio.

THNR ETF Holdings

23 of 23 holdings

  • 1

    Novo-Nordisk A/S-Spons Adr

    NVO:OSHealth Care
    11.89%
  • 2

    Eli Lilly & Co

    LLYHealth Care
    11.56%
  • 3

    Regeneron Pharmaceuticals, Inc.

    REGNHealth Care
    6.77%
  • 4

    Amgen Inc.

    AMGNHealth Care
    6.27%
  • 5

    Chugai Pharmaceutical Co., Ltd

    4519:TKUnknown
    6.00%
  • 6

    CSPC Pharmaceutical Group Limited Shs

    1093:HKHealth Care
    5.03%
  • 7

    Abbvie Inc

    ABBVHealth Care
    4.75%
  • 8

    Arrowhead Pharmaceuticals Inc

    ARWRHealth Care
    4.68%
  • 9

    Developed Markets Astrazeneca Plc Sponsored Adr

    AZN:LNHealth Care
    4.66%
  • 10

    Pfizer, Inc.

    PFEHealth Care
    4.62%
  • 11

    Merck & Company Inc

    MRKHealth Care
    4.48%
  • 12

    Roche Holding Ag

    ROG:SMUnknown
    4.46%
  • 13

    Shionogi & Co Ltd

    4507:JPUnknown
    4.46%
  • 14

    Innovent Biologics Inc

    1801:HKHealth Care
    4.43%
  • 15

    Invesco Government & Agency Portfolio, Institutional Class

    AGPXXFinancials
    2.97%
  • 16

    Scholar Rock Holding Corp

    SRRKHealth Care
    2.37%
  • 17

    Viking Therapeutics Inc Com

    VKTXHealth Care
    2.21%
  • 18

    Aud/USD Fwd 20260318

    Other
    2.05%
  • 19

    Structure Therapeutics Inc Adr

    GPCR:SHHealth Care
    2.02%
  • 20

    Zealand Pharma As

    ZEAL:COUnknown
    1.74%
  • 21

    Hanmi Pharm Co Ltd

    128940:KRUnknown
    1.28%
  • 22

    Jiangsu Hengrui Pharmaceutic

    600276:SHUnknown
    1.23%
  • 23

    Japanese Yen

    Other
    0.06%